HCW Biologics (HCWB) Enterprise Value (2020 - 2025)
HCW Biologics' (HCWB) quarterly Enterprise Value came in at -$2.0 million in Q4 2025, up 58.23% YoY from -$1.2 million in Q4 2024, and down 78.0% on a QoQ basis from -$1.1 million in Q3 2025.
HCW Biologics (HCWB) Enterprise Value (2020 - 2025) Analysis & Trends
HCW Biologics (HCWB) has 6 years of Enterprise Value data on file, last reported at -$2.0 million in Q4 2025.
- Quarterly Enterprise Value rose 58.23% year-over-year to -$2.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.0 million (up 58.23% YoY) and the FY2025 annual result came in at -$2.0 million, up 58.23% from the prior year.
- Enterprise Value fell to -$2.0 million in Q4 2025, from -$1.1 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of $27.0 million in Q2 2021 to a low of -$60.0 million in Q1 2022.
- A 5-year average of -$14.9 million and a median of -$4.7 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2021 — Enterprise Value soared 952.27% — and 2025, when it slumped 2848.35%.
- Tracing HCWB's Enterprise Value over 5 years: stood at -$36.7 million in 2021, then rose by 12.74% to -$32.0 million in 2022, then jumped by 88.78% to -$3.6 million in 2023, then slumped by 30.03% to -$4.7 million in 2024, then surged by 58.23% to -$2.0 million in 2025.
- The last three Enterprise Value figures came in at -$2.0 million (Q4 2025), -$1.1 million (Q3 2025), and -$2.4 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -3.31 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.16 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.12 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -18.39 Bn |
| 10 | HCW Biologics | 2.93 Mn | 2.19 Mn | -93,887.00 | -741,324.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.95 Mn |
| Sep 30, 2025 | -1.10 Mn |
| Jun 30, 2025 | -2.44 Mn |
| Mar 31, 2025 | -1.11 Mn |
| Dec 31, 2024 | -4.67 Mn |
| Sep 30, 2024 | -83,814.00 |
| Jun 30, 2024 | -82,723.00 |
| Mar 31, 2024 | -4.10 Mn |
| Dec 31, 2023 | -3.60 Mn |
| Sep 30, 2023 | -10.00 Mn |
| Jun 30, 2023 | -17.36 Mn |
| Mar 31, 2023 | -28.24 Mn |
| Dec 31, 2022 | -32.04 Mn |
| Sep 30, 2022 | -34.46 Mn |
| Jun 30, 2022 | -32.39 Mn |
| Mar 31, 2022 | -59.98 Mn |
| Dec 31, 2021 | -36.71 Mn |
| Sep 30, 2021 | -40.09 Mn |
| Jun 30, 2021 | 27.00 Mn |
| Dec 31, 2020 | 24.36 Mn |